FDA
-
-
-
-
-
-
-
EMD Serono Announces Unprecedented Agreement with U.S. Government to Expand Access to IVF Therapies
-
-
-
-
-
-
-
EMD Serono Unveils New MAVENCLAD® Four-Year Data Highlighting Benefits of Early Treatment and Sustained Efficacy Across Multiple Measures of Disease Activity
-
-
-
-
-
-
-
EMD Serono to Present Latest Research from Oncology Portfolio at ESMO 2023
-
-
-
-
-
-
-
EMD Serono Showcases Depth of MS Portfolio at ECTRIMS Supporting Commitment to Advancing MS Care
-
-
-
-
-
-
-
European Commission Approves TEPMETKO® (tepotinib) for Patients with Advanced NSCLC with METex14 Skipping Alterations
-
-
-
-
-
-
-
Data from EMD Serono’s Oncology Portfolio Highlight Significant Advances in Cancer Care at ASCO21
-
-
-
-
-
-
-
EMD Serono Advances Oncology Portfolio and Pipeline with New and Long-term Data in Multiple Cancers at ESMO 2020
-
322,656 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

